Form 8-K - Current report:
SEC Accession No. 0001213900-24-006119
Filing Date
2024-01-24
Accepted
2024-01-24 16:30:18
Documents
14
Period of Report
2024-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192100-8k_incannex.htm   iXBRL 8-K 26458
2 PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED JANUARY 24, 2024 ea192100ex99-1_incannex.htm EX-99.1 19350
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3710
  Complete submission text file 0001213900-24-006119.txt   231791

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ixhl-20240124.xsd EX-101.SCH 3024
5 XBRL LABEL FILE ixhl-20240124_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ixhl-20240124_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT ea192100-8k_incannex_htm.xml XML 3407
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 24556875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)